Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
ALI HEALTH Soars 10% After Midday; Exclusive Launch of World's 1st Topical Innovative Drug for Infantile Hemangioma to Kick Off Tmr
Recommend 12 Positive 16 Negative 1 |
||||
|
||||
|
Stretching last Friday's uptrend, ALI HEALTH (00241.HK) busted above the 100-day resistance at around HKD5.895 after opening around 1% higher this morning (12th). After midday, it once surged by 11.3% to a high of HKD6.42 in more than three months. It last traded at HKD6.35, up 10.05%, with a volume spiking to 292 million shares, involving HKD1.792 billion. The group announced last Thursday (8th) a strategic partnership with Beijing Merson Pharmaceutical to launch in-depth collaboration in pediatric specialty innovative drugs, promoting the omnichannel launch of timolol maleate gel, the world's first approved topical innovative drug for treating proliferative superficial infantile hemangioma. This product will be exclusively launched on the Alibaba Health platform tomorrow (13th). AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
